Francois Nader
CIK 1365343 · President, CEO and Director · last filed 2026-05-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.64M
Companies
9
Total Filings
85
Lifetime Open-Market Net
-$10.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRNA | Director | 32,781 | $49.91 | $1.64M | -$435.0K | 10 | 2026-05-08 |
| TECX | Director | — | $30.28 | — | $0 | 1 | 2026-04-03 |
| Tourmaline Bio, Inc. (TALS) Delisted | Director | 285,755 | $27.20 | $7.77M | $1.00M | 5 | 2023-06-14 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 0 | $178.75 | $0 | $0 | 11 | 2021-11-22 |
| Prevail Therapeutics Inc. (PRVL) Delisted | Director | 23,747 | — | — | $0 | 2 | 2020-06-19 |
| Baxalta Inc (BXLT) Delisted | Director | 7,657 | — | — | $0 | 2 | 2016-05-12 |
| TRVN | Director | — | $0.01 | — | $0 | 2 | 2015-05-21 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, CEO and Director | 0 | — | — | -$11.35M | 41 | 2015-02-24 |
| NOVEN PHARMACEUTICALS INC (NOVN) Delisted | Director | 0 | $0.09 | $0 | $0 | 3 | 2009-08-27 |
Recent Filings · Page 7 of 9
85 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-02-22 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-24 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-04-02 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Sell (S) | −19,350 | -$65.2K | EDGAR |
| 2010-03-18 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | +15,747 | -$24.1K | EDGAR |
| 2010-02-23 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-02-16 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-08-27 | NOVEN PHARMACEUTICALS INC (NOVN) Delisted | Disp (D) | −10,943 | -$180.6K | EDGAR |
| 2009-08-21 | NOVEN PHARMACEUTICALS INC (NOVN) Delisted | U | −3,648 | -$60.2K | EDGAR |
| 2009-05-27 | NOVEN PHARMACEUTICALS INC (NOVN) Delisted | Grant (A) | +14,591 | $0 | EDGAR |
| 2009-01-27 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.